Glaucoma surgery can reverse cupping

Article

Significantly more glaucoma patients, who are treated surgically rather than medically, will experience reversal of cupping.

Significantly more glaucoma patients, who are treated surgically rather than medically, will experience reversal of cupping, according to a study presented at the Pan-American Association of Ophthalmology congress in Cancun, Mexico.

Richard Parish, MD presented five-year data analysis from the Collaborative Initial Glaucoma Treatment Study (CIGTS). Investigators initially obtained optic disc photos from 607 patients with open angle glaucoma. Of these, 346 had follow-up photos of adequate quality, at the five-year mark, to be considered for analysis.

A total of 61 eyes were considered to have undergone changes of the optic disc and were sent to the CIGTS Optic Disc Endpoint Committee, which agreed on 45 of the 61 readings. They were surprised to discover that 25 of the eyes showed a reversal in optic disc cupping rather than the expected progression. The investigators found that 14% of patients treated surgically had undergone a reversal of cupping, compared with just 1% of those treated medically.

It was concluded that glaucoma surgery can, in some cases, reverse optic disc cupping.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
© 2025 MJH Life Sciences

All rights reserved.